Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118637315> ?p ?o ?g. }
- W2118637315 endingPage "1573" @default.
- W2118637315 startingPage "1562" @default.
- W2118637315 abstract "The division of the heterogeneous entity of diffuse large B-cell lymphoma (DLBCL) into the ontogenic phenotypes of germinal center B-cell-like (GCB) and activated B-cell-like (ABC) is optimally determined by gene expression profiling (GEP), although simpler immunohistochemistry (IHC) algorithms are alternatively being used. The cell-of-origin (COO) classification assists in prognostication and may be predictive of response to therapy. Mounting data suggests that IHC methods of classifying COO may be inaccurate. GEP categorization of COO is superior in defining prognostically and biologically distinct DLBCL subtypes, but current barriers to its widescale use include inaccessibility, cost, and lack of methodological standardization and prospective validation. The poorer prognosis of ABC-DLBCL is frequently associated with constitutive activity in the NF-κB pathway and aberrations in upstream or downstream regulators of this pathway. The molecular mechanisms underlying lymphomagenesis in GCB-DLBCL are arguably less well defined, but C-REL amplification and mutations in BCL-2 and EZH2 are common. New technologies, such as next-generation sequencing, are rapidly revealing novel pathogenic genetic aberrations, and DLBCL treatment strategies are increasingly being designed focusing on distinctive pathogenic drivers within ontogenic phenotypes. This review examines emerging molecular targets and novel therapeutic agents in DLBCL, and discusses whether stratifying therapy for DLBCL using molecular features is merited by current preclinical and clinical evidence." @default.
- W2118637315 created "2016-06-24" @default.
- W2118637315 creator A5006324385 @default.
- W2118637315 creator A5051974926 @default.
- W2118637315 creator A5056345420 @default.
- W2118637315 creator A5087876905 @default.
- W2118637315 date "2012-10-18" @default.
- W2118637315 modified "2023-10-16" @default.
- W2118637315 title "Are We Ready To Stratify Treatment for Diffuse Large B-Cell Lymphoma Using Molecular Hallmarks?" @default.
- W2118637315 cites W1608505606 @default.
- W2118637315 cites W1965213007 @default.
- W2118637315 cites W1966753131 @default.
- W2118637315 cites W1968117566 @default.
- W2118637315 cites W1970400561 @default.
- W2118637315 cites W1970739365 @default.
- W2118637315 cites W1971659434 @default.
- W2118637315 cites W1973628185 @default.
- W2118637315 cites W1973773204 @default.
- W2118637315 cites W1976174817 @default.
- W2118637315 cites W1976402300 @default.
- W2118637315 cites W1976564639 @default.
- W2118637315 cites W1976590012 @default.
- W2118637315 cites W1979816280 @default.
- W2118637315 cites W1982905137 @default.
- W2118637315 cites W1986045177 @default.
- W2118637315 cites W1988466148 @default.
- W2118637315 cites W1988703453 @default.
- W2118637315 cites W1991795177 @default.
- W2118637315 cites W1993577803 @default.
- W2118637315 cites W1994719395 @default.
- W2118637315 cites W2001985588 @default.
- W2118637315 cites W2002862326 @default.
- W2118637315 cites W2003262666 @default.
- W2118637315 cites W2008815830 @default.
- W2118637315 cites W2009002059 @default.
- W2118637315 cites W2014532100 @default.
- W2118637315 cites W2016246269 @default.
- W2118637315 cites W2016507829 @default.
- W2118637315 cites W2017978260 @default.
- W2118637315 cites W2019874087 @default.
- W2118637315 cites W2022013393 @default.
- W2118637315 cites W2024373518 @default.
- W2118637315 cites W2027818217 @default.
- W2118637315 cites W2027971058 @default.
- W2118637315 cites W2030105242 @default.
- W2118637315 cites W2030439968 @default.
- W2118637315 cites W2032981650 @default.
- W2118637315 cites W2034502116 @default.
- W2118637315 cites W2034623756 @default.
- W2118637315 cites W2035135710 @default.
- W2118637315 cites W2037796411 @default.
- W2118637315 cites W2038023916 @default.
- W2118637315 cites W2044352858 @default.
- W2118637315 cites W2051342405 @default.
- W2118637315 cites W2054076276 @default.
- W2118637315 cites W2054163626 @default.
- W2118637315 cites W2057239580 @default.
- W2118637315 cites W2058015212 @default.
- W2118637315 cites W2064208261 @default.
- W2118637315 cites W2067161281 @default.
- W2118637315 cites W2067637255 @default.
- W2118637315 cites W2083435401 @default.
- W2118637315 cites W2087849416 @default.
- W2118637315 cites W2094267033 @default.
- W2118637315 cites W2095924801 @default.
- W2118637315 cites W2096764404 @default.
- W2118637315 cites W2096984838 @default.
- W2118637315 cites W2098484165 @default.
- W2118637315 cites W2103635177 @default.
- W2118637315 cites W2103821553 @default.
- W2118637315 cites W2105549867 @default.
- W2118637315 cites W2105882193 @default.
- W2118637315 cites W2106928992 @default.
- W2118637315 cites W2107646677 @default.
- W2118637315 cites W2108399595 @default.
- W2118637315 cites W2111530307 @default.
- W2118637315 cites W2111716055 @default.
- W2118637315 cites W2115404629 @default.
- W2118637315 cites W2120415962 @default.
- W2118637315 cites W2120601121 @default.
- W2118637315 cites W2121030224 @default.
- W2118637315 cites W2125523937 @default.
- W2118637315 cites W2126372596 @default.
- W2118637315 cites W2129272684 @default.
- W2118637315 cites W2129492437 @default.
- W2118637315 cites W2133264993 @default.
- W2118637315 cites W2133869962 @default.
- W2118637315 cites W2136426653 @default.
- W2118637315 cites W2137216850 @default.
- W2118637315 cites W2138484914 @default.
- W2118637315 cites W2139954541 @default.
- W2118637315 cites W2140485109 @default.
- W2118637315 cites W2141509776 @default.
- W2118637315 cites W2141920998 @default.
- W2118637315 cites W2142766411 @default.
- W2118637315 cites W2144718749 @default.
- W2118637315 cites W2144881954 @default.
- W2118637315 cites W2145304413 @default.